Truist Financial Corp Incyte Corp Transaction History

Truist Financial Corp

$62.9 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 20, 2024	BUY	$51.18 - $63.75 $946,881 - $1.18 Million	18,501 New	18,501 $1.12 Million
Q1 2023 May 05, 2023	SELL	$70.23 - $86.01 $43,893 - $53,756	-625 Reduced 11.6%	4,762 $344,000
Q4 2022 Feb 17, 2023	BUY	$67.18 - $84.11 $361,898 - $453,100	5,387 New	5,387 $432,000
Q2 2022 Jul 22, 2022	SELL	$66.18 - $83.18 $215,217 - $270,501	-3,252 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$66.02 - $79.71 $101,538 - $122,593	-1,538 Reduced 32.11%	3,252 $258,000
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $120,282 - $140,734	-1,899 Reduced 28.39%	4,790 $352,000
Q3 2021 Nov 05, 2021	SELL	$68.67 - $84.02 $698,236 - $854,315	-10,168 Reduced 60.32%	6,689 $461,000
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $1.4 Million - $1.54 Million	-17,549 Reduced 51.01%	16,857 $1.42 Million
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $5.76 Million - $7.61 Million	-75,747 Reduced 68.77%	34,406 $2.8 Million
Q4 2020 Feb 18, 2021	BUY	$80.74 - $97.7 $562,838 - $681,066	6,971 Added 6.76%	110,153 $9.58 Million
Q3 2020 Nov 05, 2021	BUY	$85.07 - $109.69 $7,060 - $9,104	83 Added 0.08%	103,182 $9.26 Million
Q3 2020 Nov 13, 2020	BUY	$85.07 - $109.69 $986,641 - $1.27 Million	11,598 Added 12.68%	103,099 $9.25 Million
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $534,689 - $785,167	7,208 Added 8.55%	91,501 $9.51 Million
Q1 2020 May 15, 2020	BUY	$63.18 - $85.97 $387,356 - $527,082	6,131 Added 7.84%	84,293 $6.17 Million
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $5.71 Million - $7.48 Million	78,162 New	78,162 $6.83 Million
Q4 2017 Jan 29, 2018	SELL	$93.56 - $116.6 $403,150 - $502,429	-4,309 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$109.15 - $138.27 $470,327 - $595,805	4,309	4,309 $503,000

Others Institutions Holding INCY

# of Institutions

644

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account